Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures (PREV-URG)
Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures: A Multicenter, Randomized Controlled Exploratory Trial
Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. However, participation rates in France remain low compared to those of neighboring European countries, particularly with regard to cancer screenings and vaccination coverage. A lack of information, motivation, or unequal access hinders adherence to preventive measures. Some of these factors can be addressed.
Emergency departments, although rarely utilized for prevention, serve a diverse population and could serve as a strategic lever for educating the public about preventive health measures.
Personalized information, supported by a digital tool, could improve adherence to preventive measures. An interactive questionnaire was developed to tailor the information provided to patients based on their personal characteristics. The information delivered in this way would be more targeted for each patient and more likely to have a positive impact on the implementation of various preventive measures.
The purpose of this study is to determine whether a digital tool that provides personalized prevention information is more effective than general, non-personalized information in improving adherence among patients visiting the emergency department to the preventive measures recommended for them.
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Christelle JADEAU
- Número de teléfono: +332 44 71 07 81
- Correo electrónico: cjadeau@ch-lemans.fr
Copia de seguridad de contactos de estudio
- Nombre: Cyrielle HOUALARD, MD
- Número de teléfono: +332 43 43 43 43
- Correo electrónico: choualard@ch-lemans.fr
Ubicaciones de estudio
-
-
Sarthe
-
La Flèche, Sarthe, Francia, 72205
- Pôle Santé Sarthe et Loir
-
Contacto:
- Cyrielle HOUALARD, MD
- Número de teléfono: +332 44 71 30 00
- Correo electrónico: choualard@ch-lemans.fr
-
Le Mans, Sarthe, Francia, 72000
- Centre Hospitalier du Mans
-
Contacto:
- Cyrielle HOUALARD, MD
- Número de teléfono: +332 43 43 43 43
- Correo electrónico: choualard@ch-lemans.fr
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Adult patients (≥ 18 years of age)
- Patients seen in the emergency departments of Le Mans University Hospital and the PSSL
- Patients who have given their free and informed oral consent
Exclusion Criteria:
- Patients who have previously participated in the study
- Patients with limited understanding of the French language
- Patients unable to give informed consent
- Individuals not enrolled in or not eligible for a social security program
- Individuals deprived of their liberty by judicial or administrative order
- Individuals receiving involuntary psychiatric care
- Individuals subject to a legal protective measure
- Pregnant or breastfeeding patients.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: A - Intervention
The first "intervention" group, designated A, is exposed to personalized information via a digital educational tool based on the characteristics entered for them.
|
The intervention involves providing personalized preventive health information regarding recommended preventive measures based on age, biological sex, weight, height, bedtime and wake-up times, the presence of chronic conditions, and tobacco or alcohol use.
|
|
Experimental: B - Control
The second "control" group, designated B, receives non-personalized information.
Using the same digital tool, the patient receives all the preventive health information without it being tailored to the patient.
The patient therefore does not see any information specific to him or her.
|
The intervention involves providing non-personalized preventive health information.
The patient receives all the preventive health information without it being tailored to the patient.
The patient therefore does not see any information specific to him or her.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
proportion of patients who adhered to at least 25% of the preventive measures
Periodo de tiempo: 6-8 weeks after the intervention.
|
The primary outcome measure is the proportion of patients who adhered to at least 25% of the preventive measures for which they were eligible, as assessed 6-8 weeks after the intervention. Adherence is defined as the completion of a preventive measure or the initiation of steps leading to its completion in the short term |
6-8 weeks after the intervention.
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
The proportion of patients who adhered to each of the preventive measures studied.
Periodo de tiempo: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
|
The proportion of preventive measures taken by the patient, relative to the measures for which the patient is eligible.
Periodo de tiempo: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
|
The enrollment rate for each epidemiological subgroup (age, sex, whether the patient has a primary care physician, whether the patient has a chronic condition, socioeconomic status).
Periodo de tiempo: 6-8 weeks after the intervention.
|
6-8 weeks after the intervention.
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- CHM-2025/S02/17
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .